Pharmacological augmentation strategies for treatment-resistant obsessive-compulsive disorder

Author： Walsh Kelda H   McDougle Christopher J  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.10, 2004-10, pp. : 2059-2067

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Management of Treatment-Resistant Obsessive-Compulsive Disorder

By Abudy Anat   Juven-Wetzler Alzbeta   Zohar Joseph  

CNS Drugs, Vol. 25, Iss. 7, 2011-07 ,pp. : 585-596

Adis International

Access to resources Recommend Favorite

Sequential administration of augmentation strategies in treatment-resistant obsessive compulsive disorder

By Blier P.   Bergeron R.   Heacute bert C.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 370-370

Elsevier

Access to resources Recommend Favorite

Ondansetron Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Preliminary, Single-Blind, Prospective Study

By Pallanti Stefano   Bernardi Silvia   Antonini Sarah  

CNS Drugs, Vol. 23, Iss. 12, 2009-12 ,pp. : 1047-1055

Adis International

Access to resources Recommend Favorite

Aripiprazole augmentation in treatment-refractory obsessive–compulsive disorder

By Sarkar Rahul   Klein Julia   Krüger Stephanie  

Psychopharmacology, Vol. 197, Iss. 4, 2008-05 ,pp. : 687-688

Springer Publishing Company

Access to resources Recommend Favorite

Aripiprazole Addition to Serotonin Reuptake Inhibitor in Treatment-Resistant Obsessive-Compulsive Disorder

By Shoja Shafti Saeed  

Current Psychopharmacology, Vol. 3, Iss. 3, 2014-12 ,pp. : 219-225

Bentham Science Publishers

Access to resources Recommend Favorite